Demographic profile
SAD stage, SAD
In total, 70 subjects were randomized into this study (42 in the SAD stage and 28 in the MAD stage). For both stages, all subjects are Chinese with balanced distributions of age, sex, ethnicity, and BMI between ibrexafungerp and placebo groups (Demographic and clinical characteristics of subjects in the single ascending dose (SAD) stageDemographic and clinical characteristics of subjects in the multiple ascending dose (MAD) stage